We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
+16.31%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$26.7M
Cap. Flow
+$13.4M
Cap. Flow %
9.95%
Top 10 Hldgs %
35.95%
Holding
101
New
21
Increased
28
Reduced
9
Closed
20

Top Buys

1
FOLD
Amicus Therapeutics
FOLD
+$5.57M
2
ALCO icon
Alico
ALCO
+$2.28M
3
ELTX icon
Elicio Therapeutics
ELTX
+$1.81M
4
EXEL icon
Exelixis
EXEL
+$1.81M
5
MRK icon
Merck
MRK
+$1.47M

Top Sells

1
ATER icon
Aterian
ATER
+$7.86M
2
AVNW icon
Aviat Networks
AVNW
+$3.95M
3
CLPT icon
ClearPoint Neuro
CLPT
+$3.34M
4
INTC icon
Intel
INTC
+$2.49M
5
GILD icon
Gilead Sciences
GILD
+$1.75M

Sector Composition

1 Healthcare 40.52%
2 Financials 13.92%
3 Technology 12.04%
4 Energy 10.02%
5 Materials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVTA
26
DELISTED
Avantax, Inc. Common Stock
AVTA
$1.66M 1.24%
100,000
– –
SWN
27
DELISTED
Southwestern Energy Company
SWN
$1.63M 1.21%
350,000
+150,000
+75% +$606K
THFF icon
28
First Financial Corp
THFF
$927M
$1.62M 1.2%
36,000
+8,000
+29% +$340K
NHC icon
29
National Healthcare
NHC
$3.55B
$1.56M 1.16%
+20,000
New +$1.42M
TAST
30
DELISTED
Carrols Restaurant Group, Inc.
TAST
$1.55M 1.15%
258,565
– –
ET icon
31
Energy Transfer Partners
ET
$69.9B
$1.54M 1.14%
200,000
+60,000
+43% +$438K
NWLI
32
DELISTED
National Western Life Group, Inc. Class A
NWLI
$1.49M 1.11%
6,000
+4,000
+200% +$858K
B
33
Barrick Mining
B
$57.2B
$1.49M 1.1%
75,000
+35,000
+88% +$754K
VTOL icon
34
Bristow Group
VTOL
$1.32B
$1.37M 1.02%
53,000
– –
BCDA icon
35
BioCardia
BCDA
$12.8M
$1.36M 1.01%
20,873
+5,540
+36% +$346K
ALKS icon
36
Alkermes
ALKS
$8.65B
$1.31M 0.97%
+70,000
New +$1.43M
BATL icon
37
Battalion Oil
BATL
$37.9M
$1.31M 0.97%
120,000
-10,000
-8% -$102K
ARKO icon
38
ARKO Corp
ARKO
$903M
$1.29M 0.96%
+130,000
New +$1.21M
ENLC
39
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$1.29M 0.96%
300,000
-50,000
-14% -$216K
BMY icon
40
Bristol-Myers Squibb
BMY
$126B
$1.26M 0.94%
+20,000
New +$1.24M
AMGN icon
41
Amgen
AMGN
$203B
$1.24M 0.92%
+5,000
New +$1.19M
SIRI icon
42
SiriusXM
SIRI
$10.5B
$1.22M 0.91%
+20,000
New +$1.22M
KHC icon
43
Kraft Heinz
KHC
$32.1B
$1.2M 0.89%
30,000
+20,000
+200% +$720K
PTCT icon
44
PTC Therapeutics
PTCT
$6.54B
$1.18M 0.88%
25,000
– –
ATER icon
45
Aterian
ATER
$14M
$1.18M 0.88%
3,333
-20,417
-86% -$7.86M
TRC icon
46
Tejon Ranch
TRC
$509M
$1.17M 0.87%
70,000
– –
CVS icon
47
CVS Health
CVS
$139B
$1.13M 0.84%
15,000
– –
UFS
48
DELISTED
DOMTAR CORPORATION (New)
UFS
$1.11M 0.82%
30,000
– –
CHRS icon
49
Coherus Oncology
CHRS
$213M
$1.1M 0.81%
75,000
+15,000
+25% +$255K
SD icon
50
SandRidge Energy
SD
$513M
$1.09M 0.81%
280,000
– –
1
2
3 4 5

Similar funds

AA
Ahara Advisors Jersey City, New Jersey $120M AUM
CC
Commons Capital Needham, Massachusetts $120M AUM 31.45% 1-Year Est. Return
DG
Dala Group Hoffman Estates, Illinois $120M AUM
ACM
AIHC Capital Management Central $120M AUM
WAG
Windsor Advisory Group Columbus, Ohio $120M AUM 4.29% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
IW
Integrated Wealthcare Durham, North Carolina $120M AUM
BCWM
Ball & Co Wealth Management Franklin, Tennessee $120M AUM 21.28% 1-Year Est. Return

CM Management's Q1 2021 Portfolio in Review

As of Q1 2021, CM Management held 101 positions worth $135M, up 25% from $108M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

CM Management deployed $13.4M of net new capital in Q1 2021, opening 21 new positions and adding to 28 existing holdings. Its largest new stake was Elicio Therapeutics: 9,375 shares worth $1.69M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Aterian, an estimated $7.86M trimmed.

  • CM Management's largest Q1 2021 buy was Elicio Therapeutics: 9,375 shares worth $1.69M.
  • CM Management added most to Amicus Therapeutics in Q1 2021, an estimated $5.57M increase.
  • CM Management's biggest Q1 2021 reduction was Aterian, cutting an estimated $7.86M.
  • CM Management fully exited Aviat Networks in Q1 2021, selling an estimated $3.95M.
  • CM Management's ten largest holdings make up 36% of its $135M portfolio in Q1 2021.
  • CM Management opened 21 new positions and closed 20 in Q1 2021.
  • CM Management's portfolio value rose 25% quarter-over-quarter to $135M.

Based on CM Management's 13F filing for Q1 2021, filed 12 May 2021.